NYSE Content Update: Mobility Global Marks First Day as Public Company
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, July 1, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=" ...
FAIR PLAY MENARINI INTERNATIONAL AWARD: THE 30TH EDITION KICKS OFF
FLORENCE, Italy, July 1, 2026 /PRNewswire/ -- Florence opens its doors to the 30th Fair Play Menarini International Award. Today marks the opening of the event celebrating champions who have distinguished themselves not only through their sporting achievements, but also through respect, ethics, and loyalty. The traditional gala dinner at Piazzale Michelangelo...
STARMED Receives FDA 510(k) Clearance for a Benign Thyroid Nodule Ablation Indication
SEOUL, South Korea, July 1, 2026 /PRNewswire/ -- STARMED, a medical device company specialising in minimally invasive treatment technologies, has announced that it has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for a thyroid-specific indication (510(k) number: K252833). The clearance took effect on 26 May 2026. The...
Vitafoods Asia 2026: Science-Backed Botanicals and Next-Generation Probiotics Take Centre Stage
Leading Companies Present Science-Backed Solutions Addressing Antimicrobial Resistance, Digestive Health, and Wellness Through Advanced Probiotics and Clinical Botanicals BANGKOK, July 1, 2026 /PRNewswire/ -- As global healthcare confronts the urgent challenge of antimicrobial resistance, Vitafoods Asia 2026, the region's premier nutraceutical trade show organised by Informa Markets, will showcase...
PharmaResearch Accelerates REJURAN Cosmetics Expansion Across North and South America with Planned Acquisition of CG USA
Acquisition strengthens local manufacturing and logistics capabilities as REJURAN Cosmetics expands across Sephora, Amazon and Canada, with future growth across the Americas in view SEOUL, South Korea, July 1, 2026 /PRNewswire/ -- PharmaResearch, the South Korea-based regenerative medicine company behind REJURAN, is strengthening its localization strategy across North America with the planned acquisition of Cosmetic Group USA, a U.S.-based cosmetics manufacturer also known as CG USA. ...
The Hidden Cost of Efficiency: How Singapore Professionals Manage “Chronic Low-Grade Fatigue”
SINGAPORE, July 1, 2026 /PRNewswire/ -- With locals working an average of 43–45 hours per week, Singapore professionals face widespread "chronic low-grade fatigue." Research in the Journal of the American Medical Association (JAMA) links this persistent exhaustion to systemic inflammation, which impairs cognitive performance and executive focus. To combat this, elite professionals treat health as a strategic asset,...
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines across Tasmania DALLAS and HOBART, Australia, July 1, 2026 /PRNewswire/ -- The Colossal Foundation, the nonprofit conservation arm of Colossal Biosciences, today announced a new partnership...
Basecamp Research brings EDEN’s antibiotic and vaccine design models to Claude Science
Scientists can now design potent antibiotics and rapidly prioritise vaccine targets through Claude Science, thanks to integration with Basecamp Research's EDEN models. LONDON and CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ -- Basecamp Research today announced that its antibiotic design and vaccine target prediction EDEN models are now available through Claude, including Claude...
ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares
SINGAPORE, June 30, 2026 /PRNewswire/ -- ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces it has entered into a Letter of Intent ("LOI") to acquire 100% equity of CGM Medical Technology Singapore Pte. Ltd. ("CGM Medical Singapore") and assets of CGM Medical Technology Shenzhen Ltd ("CGM Medical Shenzhen") for an aggregate...
Pictor® Holdings Inc. Secures $7.5 Million Bridge Round to Accelerate Commercialization of Targeted Proteomic Platform
Investment brings Pictor's total capital raised to approximately $30 million, supporting expanded U.S. and international commercialization efforts CARLSBAD, Calif., June 30, 2026 /PRNewswire/ -- Pictor Holdings Inc., a global targeted proteomic platform company headquartered in Carlsbad, California, today announced the closing of a $7.5 million bridge round of growth capital. The financing was...
